✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
Read the full Chinese Cinnamon (Rou Gui) evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.See overview for key safety points [1]
ℹ️ Not obtained from food. Not applicable — this is not obtained from food in meaningful amounts; supplementation is the practical route.
Lab interpreter
ℹ️ No validated blood test. There is no established laboratory test to assess status or guide dosing for this ingredient. Clinical response and symptoms are the practical guide.
⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Chinese/cassia cinnamon has glucose-lowering meta-analytic evidence (FBG −24.6 mg/dL) but contains 63× more coumarin than Ceylon cinnamon. At supplement doses (1–6 g/day), cassia easily exceeds the EFSA coumarin safety limit. For chronic glucose support: use CEYLON cinnamon. For occasional cooking: cassia is fine. The coumarin-hepatotoxicity threshold is the critical clinical distinction [1].
1 How much do I need?
Adults: Specific dosage data under clinical review
Elderly: Specific dosage data under clinical review
Pregnancy: See guidance
Culinary amounts safe. Avoid concentrated cassia supplements — coumarin crosses placenta [1].
Pediatric: See guidance
Consult healthcare provider [1].
Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
Vegan: Standard dose
How to take
Timing: Per product [1].
With food: Per product [1].
Avoid: See overview [1].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['Various commercial forms', 'standard', 'See product labels [1].'] | Standard | Check label |
3 Common questions
Key clinical point ▼
Chinese/cassia cinnamon has glucose-lowering meta-analytic evidence (FBG −24.6 mg/dL) but contains 63× more coumarin than Ceylon cinnamon. At supplement doses (1–6 g/day), cassia easily exceeds the EFSA coumarin safety limit. For chronic glucose support: use CEYLON cinnamon. For occasional cooking: cassia is fine. The coumarin-hepatotoxicity threshold is the critical clinical distinction [1].
4 Clinical evidence
Strong
See overview [1]. HIGH
Moderate
See overview [1]. MODERATE
Insufficient
See overview [1]. LOW
5 Safety, toxicity & adverse events
Relative
High coumarin content (Cassia) — hepatotoxic in excess; limit daily high intake or use Ceylon
Liver disease — avoid high doses
Anticoagulants — coumarin content
Diabetes on medication — monitor glucose
Red flags
● See overview for safety concerns [1]
6 Interactions
Drug interactions
Warfarin Moderate
Mechanism: Coumarin content may potentiate anticoagulation [1].
7 Regulatory
United States (FDA): Dietary supplement [1].
8 Cite this page
Vancouver: Pkhakadze G. Chinese Cinnamon (Rou Gui) — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Nov 15]. Available from: https://supplement.ge/ingredients/chinese-cinnamon-rou-gui/
APA 7th: Pkhakadze, G. (2026). Chinese Cinnamon (Rou Gui) — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/chinese-cinnamon-rou-gui/
Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: May 2027
References: 2 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Chinese Cinnamon (Rou Gui) — Safety Profile." supplement.ge, PHIG, 2026. https://supplement.ge/ingredients/chinese-cinnamon-rou-gui/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG